Abeona Therapeutics (ABEO) Revenue & Revenue Breakdown
Abeona Therapeutics Revenue Highlights
Latest Revenue (Y)
$3.50M
Main Segment (Y)
License and Other Revenues
Main Geography (Y)
License and Other Revenues
Abeona Therapeutics Revenue by Period
Abeona Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $3.50M | 147.52% |
| 2022-12-31 | $1.41M | -52.87% |
| 2021-12-31 | $3.00M | -70.00% |
| 2020-12-31 | $10.00M | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2018-12-31 | $3.00M | 258.18% |
| 2017-12-31 | $837.00K | -5.85% |
| 2016-12-31 | $889.00K | -14.52% |
| 2015-12-31 | $1.04M | 12.43% |
| 2014-12-31 | $925.00K | -54.70% |
| 2013-12-31 | $2.04M | -53.63% |
| 2012-12-31 | $4.40M | 138.31% |
| 2011-12-31 | $1.85M | 284.20% |
| 2010-12-31 | $481.00K | 36.65% |
| 2009-12-31 | $352.00K | 20.96% |
| 2008-12-31 | $291.00K | 410.53% |
| 2007-12-31 | $57.00K | 100.00% |
| 2006-12-31 | - | 100.00% |
| 2005-12-31 | - | -100.00% |
| 2004-12-31 | $549.00K | -57.61% |
| 2003-12-31 | $1.29M | 12.90% |
| 2002-12-31 | $1.15M | 372.02% |
| 2001-12-31 | $243.00K | 127.10% |
| 2000-12-31 | $107.00K | 613.33% |
| 1999-12-31 | $15.00K | -85.00% |
| 1998-12-31 | $100.00K | -77.01% |
| 1997-12-31 | $435.00K | 160.48% |
| 1996-12-31 | $167.00K | -94.33% |
| 1995-12-31 | $2.94M | - |
Abeona Therapeutics generated $3.50M in revenue during NA 2023, up 147.52% compared to the previous quarter, and up 116.74% compared to the same period a year ago.
Abeona Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $2.82M | 100.00% |
| 2023-09-30 | - | -100.00% |
| 2023-06-30 | $3.50M | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-12-31 | $68.00K | 100.00% |
| 2022-09-30 | - | -100.00% |
| 2022-06-30 | $1.00M | 189.02% |
| 2022-03-31 | $346.00K | -88.47% |
| 2021-12-31 | $3.00M | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $3.00M | -57.14% |
| 2020-09-30 | $7.00M | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | -100.00% |
| 2018-12-31 | $-2.13M | -224.52% |
| 2018-09-30 | $1.71M | 108.67% |
| 2018-06-30 | $819.00K | -68.48% |
| 2018-03-31 | $2.60M | 1108.37% |
| 2017-12-31 | $215.00K | -1.83% |
| 2017-09-30 | $219.00K | 0.92% |
| 2017-06-30 | $217.00K | 16.67% |
| 2017-03-31 | $186.00K | -27.34% |
| 2016-12-31 | $256.00K | 39.13% |
| 2016-09-30 | $184.00K | -14.02% |
| 2016-06-30 | $214.00K | -8.94% |
| 2016-03-31 | $235.00K | 9.30% |
| 2015-12-31 | $215.00K | -24.56% |
| 2015-09-30 | $285.00K | 1.06% |
| 2015-06-30 | $282.00K | 9.30% |
| 2015-03-31 | $258.00K | 10.26% |
| 2014-12-31 | $234.00K | -0.85% |
| 2014-09-30 | $236.00K | -4.45% |
| 2014-06-30 | $247.00K | 18.75% |
| 2014-03-31 | $208.00K | 28.40% |
| 2013-12-31 | $162.00K | -14.29% |
| 2013-09-30 | $189.00K | -59.53% |
| 2013-06-30 | $467.00K | -61.85% |
| 2013-03-31 | $1.22M | 21.67% |
| 2012-12-31 | $1.01M | 15.50% |
| 2012-09-30 | $871.00K | 26.23% |
| 2012-06-30 | $690.00K | -62.80% |
| 2012-03-31 | $1.85M | 266.60% |
| 2011-12-31 | $506.00K | -51.39% |
| 2011-09-30 | $1.04M | 589.40% |
| 2011-06-30 | $151.00K | 0.67% |
| 2011-03-31 | $150.00K | 2.04% |
| 2010-12-31 | $147.00K | 15.75% |
| 2010-09-30 | $127.00K | 20.95% |
| 2010-06-30 | $105.00K | 2.94% |
| 2010-03-31 | $102.00K | -1.92% |
| 2009-12-31 | $104.00K | -27.78% |
| 2009-09-30 | $144.00K | 128.57% |
| 2009-06-30 | $63.00K | 53.66% |
| 2009-03-31 | $41.00K | -44.59% |
| 2008-12-31 | $74.00K | 57.45% |
| 2008-09-30 | $47.00K | -64.39% |
| 2008-06-30 | $132.00K | 247.37% |
| 2008-03-31 | $38.00K | -25.49% |
| 2007-12-31 | $51.00K | - |
Abeona Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Abeona Therapeutics Revenue Breakdown
Abeona Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 21 | Dec 20 | Dec 18 |
|---|---|---|---|
| License and Other Revenues | $3.00M | $10.00M | - |
| Foundation | - | - | $5.71M |
| License | - | - | $602.00K |
Abeona Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 21: License and Other Revenues (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|
| Royalty | $113.00K | $22.00K | $17.00K |
| Grant | $369.00K | $1.69M | $802.00K |
Abeona Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 18: Grant (76.56%), and Royalty (23.44%).
Abeona Therapeutics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 21 | Dec 20 | Dec 18 |
|---|---|---|---|
| License and Other Revenues | $3.00M | $10.00M | - |
| License | - | - | $602.00K |
| Foundation | - | - | $5.71M |
Abeona Therapeutics's latest annual revenue breakdown by geography, as of Dec 21: License and Other Revenues (100.00%).
Quarterly Revenue by Country
| Country | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|
| Royalty | $113.00K | $22.00K | $17.00K |
| Grant | $369.00K | $1.69M | $802.00K |
Abeona Therapeutics's latest quarterly revenue breakdown by geography, as of Dec 18: Grant (76.56%), and Royalty (23.44%).
Abeona Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals | $726.44M | $241.96M |
| RGNX | REGENXBIO | $90.24M | $22.30M |
| ADAP | Adaptimmune Therapeutics | $60.28M | $128.37M |
| FBIO | Fortress Biotech | $59.66M | $13.03M |
| PIRS | Pieris Pharmaceuticals | $42.81M | - |
| MREO | Mereo BioPharma Group | $10.00M | - |
| AFMD | Affimed | $8.28M | $155.00K |
| ABEO | Abeona Therapeutics | $3.50M | - |
| CKPT | Checkpoint Therapeutics | $103.00K | $41.00K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| BDTX | Black Diamond Therapeutics | - | - |
| XFOR | X4 Pharmaceuticals | - | $563.00K |
| CABA | Cabaletta Bio | - | - |
| RVPH | Reviva Pharmaceuticals | - | - |
| PDSB | PDS Bio | - | - |
| DAWN | Day One Biopharmaceuticals | - | $20.07M |
| INZY | Inozyme Pharma | - | - |
| LPTX | Leap Therapeutics | - | - |
| ATHA | Athira Pharma | - | - |
| CALA | Calithera Biosciences | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| IVVD | Invivyd | - | - |
ABEO Revenue FAQ
What is Abeona Therapeutics’s yearly revenue?
Abeona Therapeutics's yearly revenue for 2023 was $3.5M, representing an increase of 147.52% compared to 2022. The company's yearly revenue for 2022 was $1.41M, representing a decrease of -52.87% compared to 2021. ABEO's yearly revenue for 2021 was $3M, representing a decrease of -70.00% compared to 2020.
What is Abeona Therapeutics’s quarterly revenue?
Abeona Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). ABEO's quarterly revenue for Q4 2023 was $2.82M, a 100.00% increase from the previous quarter (Q3 2023), and a 4052.94% increase year-over-year (Q4 2022).
What is Abeona Therapeutics’s revenue growth rate?
Abeona Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 16.67%, and for the last 5 years (2019-2023) was 0%.
What are Abeona Therapeutics’s revenue streams?
Abeona Therapeutics's revenue streams in c 21 are License and Other Revenues
What is Abeona Therapeutics’s main source of revenue?
For the fiscal year ending Dec 21, the largest source of revenue of Abeona Therapeutics was License and Other Revenues. This segment made a revenue of $3M, representing 100.00% of the company's total revenue.